Ex-vivo treatment of allografts using adipose-derived stem cells induced prolonged rejection-free survival in an allogenic hind-limb transplantation model

Abstract

The <i>ex-vivo</i> pretreatment of allografts using ADSCs may function as an important adjunctive therapy for the induction of immunotolerance in VCA.